Quantum Lab® scientific and operational team
We are a multidisciplinary team that translates clinical questions into actionable research. We combine immunology, hematopoiesis, tissue engineering, bioinformatics and bioprocesses to design studies, validate findings and implement them in hospitals and academic centers. We work under protocols approved by the Ethics Commission of the UNAM and in institutional agreement with the UNAM, prioritizing rigor, transparency and measurable results.
Research fronts applied
Lines of work that connect scientific evidence with the responsible integration of our cell preparations in clinical settings.
Applied Immunology
Study of immune and MSC activation/modulation in experimental models; support in cellular pathways relevant to inflammation and differentiation.
Phytochemistry and bioprocesses
Isolation/standardization of Sechium compounds and technological development with associated plant patents and registrations.
Hematopoiesis and leukemia biology
Hematological models with drug resistance (SIRT1-p53), progenitor mobilization and biomarker definition/monitoring.
Tissue engineering and biomaterials
Polymeric scaffolds (PCL/PLGA, CNF) and functionalized surfaces for DPSC/MSC interaction, with in vitro/in vivo and 3D-printing/electrospinning validation reported by the team.
Biosensors and bioimpedance
Development/validation of electrical bioimpedance and QCM-D for detection of nucleic targets and inflammatory markers (e.g. NLRP3).
Bioinformatics and omics data
16S analysis and QIIME2/R pipelines for integration of experimental and clinical data.
Scientific and research team
Immunology and molecular biomedicine.
Alberto Parra Barrera - Ph.D.
Investigates immunomodulation and applied cell biology (MSC, inflammation, metabolism). Experience in translational projects and recent co-authorship in MSC osteogenesis; support in scientific substantiation of lines and bibliography by indication.
Tissue engineering, biomaterials and DPSC.
Raúl Rosales Ibáñez - Ph.D.
Professor UNAM FES Iztacala with background in polymeric scaffolds (PCL/PLGA) and applications in tissue regeneration; recent co-authorship in Polymers/J Biomater Appl. Support in cell-biomaterial integration and design of translational protocols.
Bioprocesses, applied phytochemistry and technology transfer.
Jorge Cadena Íñiguez - Ph.D.
Track record with >100 articles, patents and editorial direction; experience in IP and scale-up. Provides evidence pathway design and liaison with academic centers and industry for preclinical validation.
Antineoplastic activity of plant compounds; collaboration in hematopoiesis/leukemia.
Itzen Aguiñiga Sánchez - Ph.D.
PhD (COLPOS, 2022). Line manager in plant antineoplastics; experience in training and updating of manuals. Bridge towards mechanistic studies and preparation of complementary evidence.
Hematopoiesis and leukemia.
Edelmiro Santiago Osorio - Ph.D.
SNI Level 2 (2014-2022) and h-index 13; thesis direction and scientific production in biomedicine. He contributes preclinical evaluation design (in vitro/in vivo) and biomarker interpretation in hematological contexts.
Clinical molecular biology, biosensors/bioimpedance, oxidative stress and inflammation.
Modesto Gómez López - Ph.D.
PhD in Research in Medicine (ESM-IPN, 2015), postdoc in flow cytometry (UAM-I), SNI Level 1. Designs/validates molecular assays and biomarker panels (e.g., NLRP3, OGG1), with recent publications 2024-2025 in clinical and analytical methods.
Molecular biomedicine applied to tissue engineering/odontology.
Amairany Rodríguez Navarrete - M.Sc.
Co-author in Polymers/Journal of Biomaterials Applications; expertise in scaffolds and DPSC. Liaison for training, method transfer and clinical implementation support in regenerative dentistry.
Biology (UNAM); support in molecular biology and documentation.
María Guadalupe Ramírez Padilla - B.Sc.
esis on the hepatoprotective effect of SechiumDiploma in Molecular Biology (DC-3). Support in molecular procedures, experimental recording and laboratory logistics.
Clinical/molecular laboratory operation and operational support.
Bernardo José de Santiago León - Q.F.B.
QFB UdeG with experience in CEESLAB (HPV molecular biology), laboratory processes and training; provides input support, operational documentation and good practices (NOM-059) in daily operations.
Experimental support in hematopoiesis/leukemia and laboratory operation.
Ana María Altamirano Morales - B.Sc.
Biologist graduated from UNAM with experience in metabolic disease research and management of in vivo models. Specialized in laboratory techniques such as ELISA, flow cytometry, cell culture and histopathological analysis, she contributes to projects on bioactive compounds and their effect on inflammatory and metabolic processes.
Bioinformatics and omics data analysis (QIIME2/R) + molecular techniques.
Adrián Cruz Olivares - B.Sc.
Training in 16S microbiota; experience in clinical-genomic data integration (INMEGEN) and laboratory support. Provides pipelines and data normalization for exploratory evaluation.
How we collaborate with physicians and clinics
We coordinate technical advice, training and case reviews to integrate cell lines and derivatives. under protocolwith documentation and defined management parameters.
Technical advice (1:1)
Line selection, handling parameters and documentary requirements.
Continuous training
Workshops and webinars for clinical teams; method transfer and protocol updates.
Review of cases
Eligibility, biomarkers and follow-up endpoints.
Frequently asked questions - Scientific and operational equipment
Here we answer the most common questions about how the Quantum Lab team collaborates with doctors and centers. If you don't see your case, write us from the last question.
Who can request a technical session?
Health professionals and research teams linked to clinical or academic institutions. We verify specialty and institution to ensure priority attention and responsible traceability.
How do you define the right line (MSC, DPSC, NK, exosomes) for my practice?
We evaluate clinical objective, patient setting (at a high level), inclusion/exclusion criteria y center resources. The team proposes a option under protocol and documents operating parameters and next steps (not prescription).
Do they offer diagnosis, prescription or therapeutic indication?
No. Our work is technical-scientific: characterization of lines, documentation, management and monitoring parameters. The clinical decision The responsibility of the treating physician and the corresponding committees is the sole responsibility of the treating physician.
What technical documentation do I get from the equipment?
Specifications per line (e.g., ISCT criteria in MSC; CD3-/CD56+ in NK; CD63/CD81/CD9 and NTA in exosomes).
Management parameters and considerations for use under protocol.
Training material (operational checklists/SOPs, where applicable).
How is the incorporation process with the team?
Professional Application → 2) Verification → 3) Technical selection → 4) Operational plan → 5) Scientific support.
You will receive a technical minutes with agreements and next steps.
Start incorporation process
What information should I prepare to review a case?
Specialty and clinical objectiverelevant background, inclusion/exclusion criteriaapplication environment (e.g., ward/operating room), and responsible on the side of the center. We do not ask for sensitive data; if necessary, they will be treated with prior authorization.
How do you handle confidentiality and intellectual property?
We can sign confidentiality agreements and, in R&D projects, collaboration agreements that define ownership of data/results and publication criteria. All cases with academic output go through the corresponding committees.
Do you offer training to clinical teams?
Yes, programs on-demand (sessions 1:1), workshops y webinars on responsible integration, management parameters and updating of evidence.
Can they support clinical or academic research protocols?
Yes, in collaboration with institutions and within the applicable regulatory/ethical framework. We support in methodological design, endpoint definition y evidence plan (no clinical intervention).
How do I contact the right team expert?
Complete the application form indicating specialty, target y line of interest. We routed the inquiry to the scientific/commercial advisor and to the specialist for a targeted response.
Send focused consultation
How do I request a quote?
After the technical selection (line/volume/parameters), the scientific/commercial advisor shares quotation and availability for your institution.
Request quotation and availability